ArticleJournal for immunotherapy of cancer2026

Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer.

Sasha E Stanton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.